Colossal Biosciences
Colossal Biosciences raises $120M Growth at $10.2B valuation
Quick Facts
Colossal Biosciences: Growth Funding Round
Colossal Biosciences has successfully raised $120M in Growth funding, reaching a valuation of $10.2B.
Company Overview
De-extinction company using genetic engineering to revive extinct species like mammoths
Funding Details
The Growth round was led by Peter Jackson, with participation from multiple investors.
Company Information
- Headquarters: Austin, TX
- Founded: 2021
- Employees: 150+
- Category: HealthTech
Investment
Colossal Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Peter Jackson: Verified investor in Growth
- multiple investors: Verified investor in Growth
Key Investors
About the Author
Related Company Reports
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
